Effects of TNF-alpha and its Muteins on Leukemia in Mice
Author Information
Author(s): K. Warzocha, J. G6ra-Tybor, M. Kwinkowski, B. Szymarska, T. Robak
Primary Institution: Medical University of Lodz, Poland
Hypothesis
The antileukaemic activity of TNF-alpha is influenced by the nature of its N-terminal amino acids.
Conclusion
TNF-alpha can prolong survival in mice with leukemia L1210 but not in those with leukemia P388, and certain muteins can enhance this effect.
Supporting Evidence
- TNF-alpha prolonged survival of mice with leukemia L1210.
- TNF-alpha did not show therapeutic activity in leukemia P388-bearing mice.
- Muteins III, V, and VI had varying effects on survival times in leukemia models.
Takeaway
This study looked at how a protein called TNF-alpha and its modified versions can help mice with leukemia live longer. Some versions worked better than others.
Methodology
Mice were treated with TNF-alpha and its muteins, and their survival times were monitored for at least 60 days.
Limitations
The study was limited to specific types of leukemia in mice and may not directly translate to human conditions.
Participant Demographics
Young adult female DBA/2 mice, 8-12 weeks old.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website